Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Feb 23, 2021

Based on the SOLOIST-WHF and SCORED trials, there is now evidence to treat patients with HFpEF with SGLT2 inhibitors and to start treatment early in HFrEF and HFpEF. In this interview, L. Kristin Newby, MD, MHS, FACC; Deepak L. Bhatt MD, FACC; and Shashank Sinha, MD, discuss the expanding biology of SGLT2. For 20+ insider...


Feb 16, 2021

Patients with cancer presenting with a heart attack are less likely to receive invasive treatment because of perceived risks and poor outcomes. In this interview, Mamas A. Mamas, MA, DPhil, BMBCh; Ana Barac, MD, PhD, FACC; and Sun Moon Kim, MD, discuss a current study showing that patients with cancer admitted with a...


Feb 9, 2021

Increased scientific data and various guidelines now support use of computed tomography coronary angiography (CTCA) in various clinical settings. However, a knowledge gap remains regarding its usefulness in patient care. In this interview, Ron Blankstein, MD; Allen J. Taylor MD, FACC; and Poonam Velagapudi MD, MS,...


Feb 2, 2021

Peripartum heart failure can be difficult to recognize because the symptoms may be similar to those of normal pregnancy; however, it’s important to make the diagnosis so that women can receive the correct medications and treatment. In this interview, Michelle Kittleson, MD, FACC; Melinda B. Davis, MD, FACC; and Jeffrey...


Jan 26, 2021

Clinical studies have reported a prevalence of myocardial infarction with nonobstructive coronary arteries (MINOCA) of 5-6% of acute myocardial infarction cases, with a range of 5-15% depending on the population examined. In this interview, Deepak L. Bhatt, MPH, MD, FACC; Vijay Kunadian, MBBS, MD, FACC; and Michelle Kelsey, MD,...